Biochemical markers in preclinical models of osteoporosis.

Biochemical markers in preclinical models of osteoporosis.

Item
http://www.wikidata.org/entity/Q36799410
In vivo screening for anti-osteoporotic fraction from extract of herbal formula Xianlinggubao in ovariectomized miceAlterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast qualityβ-Catenin independent cross-control between the estradiol and Wnt pathways in osteoblastsPiezosurgery: A new and safe technique for distraction osteogenesis in Pierre Robin sequence review of the literature and case report.Rapidly assessing changes in bone mineral balance using natural stable calcium isotopesEffect of combined sex hormone replacement on bone/cartilage turnover in a murine model of osteoarthritis.Expression of an estrogen receptor agonist in differentiating osteoblast cultures.The osteogenic transcription factor runx2 controls genes involved in sterol/steroid metabolism, including CYP11A1 in osteoblasts.Models and screening assays for drug discovery in osteoporosis.Particle-induced osteolysis is not accompanied by systemic remodeling but is reflected by systemic bone biomarkers.
P2860

Biochemical markers in preclinical models of osteoporosis.

Item
http://www.wikidata.org/entity/Q36799410
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Biochemical markers in preclinical models of osteoporosis.
@en
type
label
Biochemical markers in preclinical models of osteoporosis.
@en
prefLabel
Biochemical markers in preclinical models of osteoporosis.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Biochemical markers in preclinical models of osteoporosis.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921